Ensysce Biosciences engages Alacrita Consulting to explore partnering and licensing opportunities for its TAAP and MPAR platforms and products. The company describes Alacrita as a pharma and biotech consulting firm, and its announcement identifies Ensysce Biosciences as a Nasdaq-listed company trading as ENSC.
Life science consulting firm Alacrita appoints Anna Casse as its new managing director, giving her responsibility for Alacrita Europe and a role in building its European Launch platform. Casse joins from BioVault, where she served as chief executive officer.
Alacrita appoints Pierre Dodion as an associate partner in its Cambridge, Massachusetts office, adding him to the transatlantic life sciences consulting firm. Dodion previously served as senior vice president of corporate development and operations at ARIAD Pharmaceuticals; the announcement is dated January 20, 2014.
